Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

AE 941

Drug Profile

AE 941

Alternative Names: Arthrovas; Neoretna; Neovastat; Psovascar; Shark cartilage extract AE 941

Latest Information Update: 17 Aug 2017

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator AEterna Zentaris Inc
  • Class Antineoplastics; Antipsoriatics
  • Mechanism of Action Angiogenesis inhibitors; Metalloprotease inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Renal cancer
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Age-related macular degeneration; Breast cancer; Multiple myeloma; Non-small cell lung cancer; Osteoarthritis; Prostate cancer; Psoriasis; Renal cancer; Rheumatoid arthritis

Most Recent Events

  • 05 Mar 2007 Discontinued - Phase-III for Non-small cell lung cancer in Canada (PO)
  • 05 Mar 2007 Discontinued - Phase-III for Non-small cell lung cancer in USA (PO)
  • 17 Feb 2006 The US National Cancer Institute has interrupted enrolment in a phase III trial for Non-small cell lung cancer in the USA and Canada
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top